ACEA Biosciences
James O'Connell has worked in various roles and positions in the field of biosciences and diagnostics. James started their career at Ortho Clinical Diagnostics in 1988 as the Vice President of R&D. James held this position until 1995. In 1994, O'Connell joined Nanogen, Inc. as the VP of R&D and stayed with the company until 2001. James then became the CEO of ACEA Biosciences, but the specific start and end dates are unknown. Overall, O'Connell has demonstrated significant experience and expertise in research and development within the biosciences industry.
James O'Connell attended the University of North Carolina at Chapel Hill from 1973 to 1977. No specific degree or field of study was mentioned.
This person is not in any teams
ACEA Biosciences
ACEA Biosciences is a biotechnology company founded in 2002 and headquartered in San Diego, California. ACEA is a pioneer in the development and commercialization of high-performance microelectronic systems for cell-based assays. ACEA has a world-class manufacturing operation centered in Hangzhou, Zhejiang Province, China.The Life TechnologyBusiness Unit developed ACEA’s proprietary real-time, label-free cell-based assay technology and launched the first product in 2004. The technology has been marketed globally under the xCELLigence brand. There are over 800 customers worldwide, and over 350 peer-reviewed publications using the xCELLigence technology.The newly launched iCELLigence instrument with wireless connectivity makes this innovative technology affordable to all users. In addition to the Life Technology Business Unit, ACEA also has a Therapeutics Business Unit which was launched in 2005.ACEA Therapeutics is focused on oncology drug discovery and development, leveraging the platform biosensor technology and proprietary small molecule library (> 1 million compounds) to bring novel therapeutics into the clinic. ACEA currently has one program in phase II clinical trials in China and numerous early clinical and preclinical leads. With its international reach, ACEA Biosciences continues to work closely with scientists throughout the world to bring innovation to the R&D and health care industries.